HARRIS ROBERT B

CIK 00012376331 companyRICHMOND, VA

SEC Profile

Transactions

Companies

Filings

CIK

0001237633

Recent Transactions

32 trades

Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2008-12-29+25,000→ 70,064 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2008-12-29+25,000→ 70,064 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2008-03-06+1,315→ 55,064 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2008-03-06+1,315→ 55,064 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2008-01-03+30,000→ 86,562 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2008-01-03+30,000→ 86,562 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2007-01-02+1,314→ 53,749 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2007-01-02+1,314→ 53,749 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2005-02-03$5.35/sh+20,000→ 139,460 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2005-02-03$5.35/sh+20,000→ 139,460 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2005-01-03$6.00/sh+10,000→ 119,460 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2005-01-03$6.00/sh+10,000→ 119,460 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Options
2004-04-05−10,000→ 109,460 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2004-04-05$3.85/sh+10,000→ 61,121 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2004-04-05$9.69/sh−10,000→ 51,121 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2004-04-05$3.85/sh+10,000→ 61,121 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Options
2004-04-05−10,000→ 109,460 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2004-04-05$9.69/sh−10,000→ 51,121 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2003-11-12+10,000→ 151,910 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options
2003-11-12+10,000→ 151,910 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.20/sh−900→ 53,221 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.15/sh−900→ 51,121 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.16/sh−1,200→ 52,021 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.15/sh−900→ 51,121 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.16/sh−1,200→ 52,021 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.20/sh−900→ 53,221 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.15/sh−900→ 51,121 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.15/sh−900→ 51,121 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.20/sh−900→ 53,221 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.16/sh−1,200→ 52,021 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.20/sh−900→ 53,221 total
Sale
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2003-07-17$3.16/sh−1,200→ 52,021 total

Companies

Inhibitor Therapeutics, Inc.
Director, President
$INTI

Recent Filings

Address

601 BIOTECH DRIVE

RICHMOND, VA, 23235

View on SEC.gov